2,381 Shares in Danaher Corporation $DHR Bought by Proficio Capital Partners LLC

Proficio Capital Partners LLC purchased a new stake in Danaher Corporation (NYSE:DHR) in the 2nd quarter, HoldingsChannel reports. The fund purchased 2,381 shares of the conglomerate’s stock, valued at approximately $454,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. High Note Wealth LLC lifted its stake in shares of Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after buying an additional 47 shares in the last quarter. First Command Advisory Services Inc. raised its holdings in shares of Danaher by 4.4% in the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after acquiring an additional 47 shares during the last quarter. GW&K Investment Management LLC raised its holdings in shares of Danaher by 8.4% in the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after acquiring an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC lifted its position in Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after acquiring an additional 48 shares in the last quarter. Finally, SOL Capital Management CO boosted its stake in Danaher by 2.7% during the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock valued at $430,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.2%

Shares of DHR stock opened at $215.74 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market capitalization of $151.67 billion, a price-to-earnings ratio of 38.32, a PEG ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a 50-day simple moving average of $198.69 and a two-hundred day simple moving average of $192.35.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter last year, the firm earned $0.77 EPS. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. Research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. Piper Sandler initiated coverage on Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Guggenheim decreased their price target on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Finally, Evercore reissued an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.